Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Michael Leo and Carmit McMullen.
Connection Strength

2.642
  1. Development of a Goal Elicitation Measure to Support Bladder Cancer Patient Choice about Urinary Diversion. J Urol. 2019 Mar 05; 101097JU0000000000000203.
    View in: PubMed
    Score: 0.670
  2. Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomy. Urol Oncol. 2024 Oct 14.
    View in: PubMed
    Score: 0.247
  3. The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy. Qual Life Res. 2020 Apr; 29(4):879-889.
    View in: PubMed
    Score: 0.177
  4. External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system. Urol Oncol. 2020 02; 38(2):39.e21-39.e27.
    View in: PubMed
    Score: 0.176
  5. Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy. J Urol. 2020 01; 203(1):159-163.
    View in: PubMed
    Score: 0.173
  6. Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer. Perm J. 2019; 23.
    View in: PubMed
    Score: 0.173
  7. Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems. Urology. 2019 Mar; 125:222-229.
    View in: PubMed
    Score: 0.164
  8. Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing. Am J Med Genet A. 2016 Mar; 170(3):574-82.
    View in: PubMed
    Score: 0.135
  9. "Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening. J Genet Couns. 2016 Feb; 25(1):135-45.
    View in: PubMed
    Score: 0.130
  10. ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. Genet Med. 2022 May 06.
    View in: PubMed
    Score: 0.052
  11. Economic Evaluation: A Randomized Pragmatic Trial of a Primary Care-based Cognitive Behavioral Intervention for Adults Receiving Long-term Opioids for Chronic Pain. Med Care. 2022 Mar 30.
    View in: PubMed
    Score: 0.052
  12. A Primary Care-Based Cognitive Behavioral Therapy Intervention for Long-Term Opioid Users With Chronic Pain : A Randomized Pragmatic Trial. Ann Intern Med. 2022 Jan; 175(1):46-55.
    View in: PubMed
    Score: 0.050
  13. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population. Fam Cancer. 2021 Mar 23.
    View in: PubMed
    Score: 0.048
  14. A decision aid for additional findings in genomic sequencing: Development and pilot testing. Patient Educ Couns. 2021 05; 104(5):960-968.
    View in: PubMed
    Score: 0.047
  15. Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort. Cancer. 2021 02 15; 127(4):520-527.
    View in: PubMed
    Score: 0.047
  16. Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. Health Aff (Millwood). 2018 05; 37(5):809-816.
    View in: PubMed
    Score: 0.040
  17. Patient actions and reactions after receiving negative results from expanded carrier screening. Clin Genet. 2018 May; 93(5):962-971.
    View in: PubMed
    Score: 0.039
  18. Interdisciplinary team-based care for patients with chronic pain on long-term opioid treatment in primary care (PPACT) - Protocol for a pragmatic cluster randomized trial. Contemp Clin Trials. 2018 04; 67:91-99.
    View in: PubMed
    Score: 0.039
  19. Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing. J Genet Couns. 2018 Aug; 27(4):823-833.
    View in: PubMed
    Score: 0.039
  20. The NextGen Study: patient motivation for participation in genome sequencing for carrier status. Mol Genet Genomic Med. 2017 Sep; 5(5):508-515.
    View in: PubMed
    Score: 0.037
  21. Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing. J Genet Couns. 2017 Oct; 26(5):971-979.
    View in: PubMed
    Score: 0.037
  22. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Contemp Clin Trials. 2017 02; 53:100-105.
    View in: PubMed
    Score: 0.036
  23. Generating a taxonomy for genetic conditions relevant to reproductive planning. Am J Med Genet A. 2016 Mar; 170(3):565-73.
    View in: PubMed
    Score: 0.034

© 2024 Kaiser Permanente